Safety and immunologic activity of anakinra in HER2-negative metastatic breast cancer (MBC).

e14565Background: Higher intratumoral IL-1b levels correspond with advanced stages of MBC. We hypothesized that anakinra (Ank), an IL-1R antagonist, may decrease tumor inflammation and improve outc...